Cargando…
Insights into Aptamer–Drug Delivery Systems against Prostate Cancer
Prostate cancer is a common cancer in elderly males. Significant progress has been made in the drug therapies for prostate cancer in recent years. However, side effects are still problems that have not been overcome by the currently used anti-prostate cancer drugs. Novel technologies can be applied...
Autores principales: | Wang, Xueni, Zhou, Qian, Li, Xiaoning, Gan, Xia, Liu, Peng, Feng, Xiaotao, Fang, Gang, Liu, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182114/ https://www.ncbi.nlm.nih.gov/pubmed/35684384 http://dx.doi.org/10.3390/molecules27113446 |
Ejemplares similares
-
Pharmacological Small Molecules against Prostate Cancer by Enhancing Function of Death Receptor 5
por: Gan, Xia, et al.
Publicado: (2022) -
Analysis of regulating activities of 5′-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo
por: Wang, Xueni, et al.
Publicado: (2022) -
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018) -
Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010) -
Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
por: Ma, Qi, et al.
Publicado: (2019)